Results

Titan Pharmaceuticals Inc.

08/09/2024 | Press release | Archived content

XBRL Q2 2024

Quarterly report pursuant to Section 13 or 15(d)

Cover

Cover - shares

6 Months Ended

Jun. 30, 2024

Aug. 09, 2024

Cover [Abstract]
Document Type 10-Q
Amendment Flag false
Document Quarterly Report true
Document Transition Report false
Document Period End Date Jun. 30, 2024
Document Fiscal Period Focus Q2
Document Fiscal Year Focus 2024
Current Fiscal Year End Date --12-31
Entity File Number 001-13341
Entity Registrant Name Titan Pharmaceuticals, Inc.
Entity Central Index Key 0000910267
Entity Tax Identification Number 94-3171940
Entity Incorporation, State or Country Code DE
Entity Address, Address Line One 400 Oyster Point Blvd.
Entity Address, Address Line Two Suite 505
Entity Address, City or Town South San Francisco
Entity Address, State or Province CA
Entity Address, Postal Zip Code 94080
City Area Code (650)
Local Phone Number 244-4990
Title of 12(b) Security Common Stock, par value $0.001
Trading Symbol TTNP
Security Exchange Name NASDAQ
Entity Current Reporting Status Yes
Entity Interactive Data Current Yes
Entity Filer Category Non-accelerated Filer
Entity Small Business true
Entity Emerging Growth Company false
Entity Shell Company false
Entity Common Stock, Shares Outstanding 914,234